-

Horizon Therapeutics Named 2020 Top Workplace for Millennials by Fortune

DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (NASDAQ: HZNP) today announced that it has been named to the 2020 Fortune Best Workplaces for Millennials™ list. Horizon ranked 7th among 25 companies in the small and medium company category in its first year on the list.

“We’re proud that Fortune and Great Place to Work recognized the focus we put on developing employees at each phase of their careers, including those in the beginning stages,” said Tim Walbert, chairman, president and chief executive officer, Horizon. “Our best-in-class benefits and employee support programs have helped Horizon get to where it is today and we will continue to do everything we can to retain the top talent that helps meet the needs of the patients we serve.”

Horizon’s competitive benefits include Horizon’s Match+ program for which the company matches employee donations to non-profits up to $500. Employees are also encouraged to take a “Make It Personal Day” annually to do something meaningful to them. Additionally, the company encourages all employees to actively pursue career development and further their education – of the 2020 Horizon Executive Scholarship Award recipients, all six are millennials.

To determine the Fortune Best Workplaces for Millennials list, Fortune and Great Place to Work conducted an anonymous survey of nearly 4.9 million employees responding to questions describing the extent to which their organization creates a Great Place to Work For All™. Eighty-five percent of the evaluation was based on what millennials say about their experiences of trust and reaching their full human potential as part of their organization, no matter who they are or what they do.

About Horizon

Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

About the Best Workplaces for Millennials

Great Place to Work based its ranking on a data-driven methodology applied to anonymous Trust Index™ survey responses representing over 4.9 million employees at Great Place to Work-Certified organizations. To learn more about Great Place to Work Certification and recognition on Best Workplaces lists published with Fortune, visit Greatplacetowork.com.

Contacts

U.S. Media Contact:
Geoffrey Curtis
Executive Vice President, Corporate Affairs & Chief Communications Officer
media@horizontherapeutics.com

Ireland Media Contact:
Ray Gordon
Gordon MRM
ray@gordonmrm.ie

Horizon Therapeutics plc

NASDAQ:HZNP

Release Versions

Contacts

U.S. Media Contact:
Geoffrey Curtis
Executive Vice President, Corporate Affairs & Chief Communications Officer
media@horizontherapeutics.com

Ireland Media Contact:
Ray Gordon
Gordon MRM
ray@gordonmrm.ie

More News From Horizon Therapeutics plc

Rule 17(e) Announcement - Horizon Therapeutics plc

DUBLIN--(BUSINESS WIRE)--  NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE October 6, 2023 RECOMMENDED CASH OFFER for HORIZON THERAPEUTICS PLC by Pillartree Limited, a private limited company wholly owned by Amgen Inc. to be implemented by way of a scheme of arrangement under Chapter 1 of Part 9 of...

Rule 17(d) Announcement – Horizon Therapeutics plc

DUBLIN--(BUSINESS WIRE)--  NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION October 5, 2023 RECOMMENDED CASH OFFER for HORIZON THERAPEUTICS PLC by Pillartree Limited, a private limited company wholly owned by Amgen Inc. to be implemented by way of a scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies A...

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

DUBLIN--(BUSINESS WIRE)--IRISH TAKEOVER PANEL DEALING DISCLOSURE UNDER RULE 8.1(c) AND (d)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR, OFFEREE OR PARTIES ACTING IN CONCERT WITH THEM IN RESPECT OF DEALINGS FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS 1. KEY INFORMATION (a) Full name of discloser: Elizabeth Crossan (b) Owner or controller of interests and short positions disclosed, if different from 1(a):   The naming of nominee or vehicle companies is insufficien...
Back to Newsroom